Arthneeti
Sale is live|00:00:00

Yasho Industries Ltd Q3 FY26 Earnings Analysis

Published 15 Jul 2026 | Chemicals & Petrochemicals | Market Cap: ₹2.0K Cr

Price

3,091

Market Cap

₹2.0K Cr

P/E Ratio

113.4

Earnings Summary

- Expected revenue for the full year is around INR 800 to 850 crores, adjusted down from an earlier INR 900 crores guidance due to tariff issues. - Yasho Industries expects EBITDA margins to be maintained in the 17%-19% range through FY '27.

📊 Revenue & Sales Performance

- Expected revenue for the full year is around INR 800 to 850 crores, adjusted down from an earlier INR 900 crores guidance due to tariff issues. (Page 12) - Long-term revenue projection linked to INR 75 crores capex expected to generate roughly INR 250 crores. (Page 16) - Volume growth of 30% observed currently, with confidence to maintain or improve this via diversified markets. (Page 13) - Export sales expected to grow to approximately 70% of total sales within 6 to 18 months. (Page 10) - Asset turnover ratio targeted to reach 3x in 3 to 4 years, with gradual capacity ramp-up. (Page 12) - Volume growth prioritized as a key metric alongside EBITDA over topline fluctuations. (Page 8) - Some capacity expansions may take 18-24 months to reach optimal utilization. (Page 16) - New customers may contribute around 10-15% of revenue moving forward. (Page 15)

📈 Profitability & Margins

- Yasho Industries expects EBITDA margins to be maintained in the 17%-19% range through FY '27. - Revenue guidance for full year FY '26 is revised to INR 800-850 crores, down from earlier INR 900 crores due to tariff impacts. - Volume growth and EBITDA growth are key performance metrics, focusing more on volume than top-line growth. - Long-term supply agreement with a global MNC is projected to add ~INR 150 crores in annual revenues from FY '27 end. - Capex related to capacity expansion will partially come online from Jan-Feb 2026, with full impact expected mid-2026. - Debt-to-EBITDA ratio is targeted to improve to 3-3.5x by FY '27 through growth-driven cash flow, despite no absolute debt reduction planned. - Asset turnover ratio is aimed to reach ~3x over 3-4 years as capacity utilization improves. - EPS growth is expected alongside volume and EBITDA growth, supported by stable margins and strategic capex deployment.

🏗️ Capital Expenditure Plans

- Ongoing capex expanding capacity with part production expected to start by Jan-Feb 2026 (not debottlenecking Phase 1, but expansion of existing product line). - Total planned capex of INR100 crores for the year; INR23 crores spent on R&D, INR20 crores on assets, balance INR45 crores pending pending clarity on tariff and business climate. - Additional capex (INR50-75 crores) planned in conjunction with a global MNC customer for lubricant derivatives, funded by the customer, with operations starting by Q4 FY '27, expected to contribute ~INR150 crores annual revenue from FY '27 end. - Management is cautious about further capex in FY '27, aiming to prioritize utilization of existing capacity and await tariff clarity before committing new investments. - R&D investment increasing with a newly commissioned R&D lab (INR23 crores invested), targeting INR8-10 crores in R&D opex for FY '27 to drive innovation and product development.

💰 Fundraising & Capital Structure

- No specific plans to reduce absolute debt currently; management expects debt-to-EBITDA ratio to improve significantly by FY '27 (target between 3.0 to 3.5). - No mention of any upcoming new debt or equity fundraising explicitly. - Capex plans are on hold pending clarity on tariff and business climate; no large new capex planned for FY '27, aiming to fully utilize existing capacity first. - Management is cautious and prefers waiting for market clarity before committing additional funds. - Existing long-term debt repayments have started from April 2025, with no moratorium. - Focus remains on improving cash flow, working capital discipline, and gradual leverage reduction rather than active new fundraising.

📋 Order Book & Pipeline

The transcript does not explicitly provide details regarding the current or expected order book or pending orders for Yasho Industries Limited. However, the following relevant points can be inferred: - The company is experiencing a tariff impact affecting business, especially in the US, but is seeing mitigation efforts and some order flow returning. - New customer acquisitions and expansion into new geographies are underway, with expectations of incremental business growth. - Capex is partly on hold pending clarity on tariffs; some lines will become operational by Jan-Feb 2026, expected to contribute to revenue. - The company anticipates a total revenue growth of INR 800-850 crores for FY26, down from higher earlier guidance due to tariff impact. - There is mention of long-term agreements with customers, including a 15-year contract with capex funding by a client, implying a stable order base. No specific quantitative order book or pending order values are disclosed.

Key Metrics

Frequently Asked Questions

What were Yasho Industries Ltd Q3 FY26 results?

- Expected revenue for the full year is around INR 800 to 850 crores, adjusted down from an earlier INR 900 crores guidance due to tariff issues. - Yasho Industries expects EBITDA margins to be maintained in the 17%-19% range through FY '27.

What is Yasho Industries Ltd share price analysis?

Yasho Industries Ltd currently shows a neutral. The stock trades at a P/E of 113.4 with a market cap of ₹2,045. Investors should review the full earnings analysis for detailed insights.

Is Yasho Industries Ltd planning capital expenditure?

- Ongoing capex expanding capacity with part production expected to start by Jan-Feb 2026 (not debottlenecking Phase 1, but expansion of existing product line).

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.